Počet záznamů: 1  

Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts

  1. 1.
    0380633 - FGÚ 2013 RIV CA eng J - Článek v odborném periodiku
    Neckář, Jan - Boudíková, Adéla - Mandíková, Petra - Štěrba, M. - Popelová, O. - Mikšík, Ivan - Dabrowská, L. - Mráz, J. - Geršl, V. - Kolář, František
    Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts.
    Canadian Journal of Physiology and Pharmacology. Roč. 90, č. 9 (2012), s. 1303-1310. ISSN 0008-4212. E-ISSN 1205-7541
    Grant CEP: GA AV ČR(CZ) IAAX01110901; GA ČR(CZ) GA305/09/0416
    Výzkumný záměr: CEZ:AV0Z50110509
    Klíčová slova: heart * dexrazoxane * ischaemia * reperfusion * infarct size * arrhythmias * cardioprotection * reactive oxygen species
    Kód oboru RIV: FR - Farmakologie a lékárnická chemie
    Impakt faktor: 1.556, rok: 2012

    The aim of our study was to find out whether dexrazoxane (DEX) treatment reduces myocardial infarct size and arrhythmias induced by regional I/R in open-chest rats and in isolated perfused hearts, and to find out its most effective dose. Our results showed that DEX in the single dose of 150 mg•kg–1 effectively suppressed ventricular arrhythmias in isolated hearts subjected to acute I/R, but it was insufficient to reduce arrhythmias in open-chest animals, and only the highest dose of DEX (450 mg•kg–1) decreased myocardial infarct size. The protective effects of DEX were not accompanied by decreases of oxidative stress markers in the myocardium, suggesting that other protective mechanism(s) than limitation of ROS formation might play a role
    Trvalý link: http://hdl.handle.net/11104/0211289

     
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.